Form 8-K - Current report:
SEC Accession No. 0001299933-11-002430
Filing Date
2011-08-05
Accepted
2011-08-05 10:17:56
Documents
3
Period of Report
2011-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_42600.htm 8-K 10663
2 EX-99.1 exhibit1.htm EX-99.1 90655
3 GRAPHIC e34259-112161730174359e33_1.jpg GRAPHIC 26836
  Complete submission text file 0001299933-11-002430.txt   139561
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 111012604
SIC: 2834 Pharmaceutical Preparations